Recombinant Fusion Protein April 12, 2017 Recombinant Fusion Protein Trade Name Orphan Indication Myelodysplastic Syndrome USA Market Approval USA USA Designation Date 2012-07-24 00:00:00 Sponsor Apogenix GmbH;Im Neuenheimer Feld 584, 69120;Heidelberg
